1. Date and Time | Date | 2022-03-25 |
Time | AM 10:30 | |
2. Place | Global R&D Center Hall, 22, Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea | |
3. Agenda and Key Issues |
1. Matters to report 1) Audit report 2) Business report 3) Report on the operation of the Internal Accounting Management System 2. Agenda items - Agenda 1: Approval of financial statements for the 7th fiscal year - Agenda 2: Approval of Amendments to the Articles of Incorporation - Agenda 3: Approval of annual cap on directors' remuneration - Agenda 4: Approval of granting stock options. - Agenda 5: Approval of stock options granted by the Board of Directors | |
4. Date of Board of Directors' Resolution(Decision Date) | 2022-03-07 | |
-Outside Directors in Attendance | Number Present | 3 |
Number Absent | - | |
-Auditors in Attendance (on Audit Committee who are not outside directors) | - | |
-Type of Shareholders' Meeting | Annual Meeting | |
5. Other references concerning investment decisions | ||
- | ||
※Title and date of other disclosure related to this one | - |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Bridge Biotherapeutics Inc. published this content on 08 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 March 2022 01:00:08 UTC.